Valion Bio, Inc. (VBIO)
1.17
-0.06
(-4.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
Valion Bio Price : 1.17 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.23 | 1.24 | 1.130 | 1.17 | 274624.0 |
| Oct 15, 2026 | 1.11 | 1.33 | 1.11 | 1.23 | 13.73M |
| Oct 14, 2026 | 1.54 | 1.55 | 1.435 | 1.45 | 160595.0 |
| Oct 13, 2026 | 1.68 | 1.68 | 1.47 | 1.55 | 179679.0 |
| Oct 12, 2026 | 2.10 | 2.14 | 1.59 | 1.68 | 250121.0 |
| Oct 09, 2026 | 2.19 | 2.270 | 2.10 | 2.14 | 140567.0 |
| Oct 08, 2026 | 2.07 | 2.28 | 2.07 | 2.21 | 150959.0 |
| Oct 07, 2026 | 2.31 | 2.38 | 2.18 | 2.19 | 129167.0 |
| Oct 06, 2026 | 2.36 | 2.48 | 2.330 | 2.38 | 129201.0 |
| Oct 05, 2026 | 2.42 | 2.49 | 2.30 | 2.48 | 311360.0 |
| Oct 02, 2026 | 2.55 | 2.69 | 2.456 | 2.59 | 245138.0 |
| Oct 01, 2026 | 2.55 | 2.75 | 2.48 | 2.51 | 681409.0 |
| Sep 30, 2026 | 4.00 | 4.39 | 2.53 | 2.80 | 52.29M |
| Sep 29, 2026 | 2.63 | 3.118 | 2.41 | 2.83 | 381273.0 |
| Sep 28, 2026 | 2.82 | 3.03 | 2.65 | 2.70 | 220632.0 |
| Sep 25, 2026 | 3.34 | 3.499 | 2.79 | 3.03 | 751768.0 |
| Sep 24, 2026 | 2.62 | 3.79 | 2.32 | 3.48 | 10.75M |
| Sep 23, 2026 | 2.45 | 3.29 | 2.254 | 2.73 | 2.109M |
| Sep 22, 2026 | 2.41 | 2.80 | 2.360 | 2.49 | 544710.0 |
| Sep 21, 2026 | 2.138 | 2.45 | 2.132 | 2.38 | 127407.0 |
| Sep 18, 2026 | 2.29 | 2.36 | 2.12 | 2.12 | 57618.00 |
| Sep 17, 2026 | 2.16 | 2.44 | 2.12 | 2.23 | 216675.0 |
| Sep 16, 2026 | 2.05 | 2.26 | 2.05 | 2.08 | 115432.0 |
| Sep 15, 2026 | 2.12 | 2.17 | 2.059 | 2.11 | 33967.00 |
| Sep 14, 2026 | 2.25 | 2.42 | 2.10 | 2.10 | 149598.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Outlook Therapeutics, Inc. | 0.4882 |
| Agenus, Inc. | 6.04 |
| Amgen, Inc. | 432.49 |
| Anika Therapeutics, Inc. | 19.98 |
| BioCryst Pharmaceuticals, Inc. | 7.79 |
Price Related Metrics
| PS Ratio | 0.6784 |
| Price to Book Value | 0.0458 |
| Earnings Yield | -17.97K% |
| Market Cap | 0.1943M |